NDC 51655-091

Levothyroxine

Levothyroxine

Levothyroxine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Northwind Pharmaceuticals, Llc. The primary component is Levothyroxine Sodium.

Product ID51655-091_e561a5af-c541-4ef0-b027-9d1af884ac72
NDC51655-091
Product TypeHuman Prescription Drug
Proprietary NameLevothyroxine
Generic NameLevothyroxine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-07-10
Marketing CategoryNDA / NDA
Application NumberNDA021342
Labeler NameNorthwind Pharmaceuticals, LLC
Substance NameLEVOTHYROXINE SODIUM
Active Ingredient Strength25 ug/1
Pharm Classesl-Thyroxine [EPC],Thyroxine [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51655-091-52

30 TABLET in 1 BOTTLE, DISPENSING (51655-091-52)
Marketing Start Date2014-07-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51655-091-52 [51655009152]

Levothyroxine TABLET
Marketing CategoryNDA
Application NumberNDA021342
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-07-10
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
LEVOTHYROXINE SODIUM25 ug/1

OpenFDA Data

SPL SET ID:3177aea1-c0c6-4ae1-b20e-3ca66a949e2c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 966220
  • Pharmacological Class

    • l-Thyroxine [EPC]
    • Thyroxine [CS]

    NDC Crossover Matching brand name "Levothyroxine" or generic name "Levothyroxine"

    NDCBrand NameGeneric Name
    43742-0955LevothyroxineLevothyroxine
    51655-091LevothyroxineLevothyroxine
    51655-290LEVOTHYROXINELEVOTHYROXINE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.